Syneron Medical, a company from Israel, just received approval from the FDA to market their new minimally invasive laser-assisted lypolysis machine, in which laser heats, destroys, and coagulates subdermal tissue.
From the press release:
For patients, LipoLite is both a minimally invasive alternative and a complement to traditional liposuction fat-removing procedures. The procedure requires only local anesthetic and is designed to provide patients lasting results with little downtime and a high level of safety. For physicians, the small, compact LipoLite system is comfortable to use, upgradeable to support future applications and fits easily on tabletops to save floor space in small operating rooms where space can be at a premium.
From the product page:
LipoLite causes fat cells to break apart and be eliminated by the body through non-selective heating of the adipose tissue. The 1064nm Nd:YAG laser energy is delivered via an optical fiber inside a cannula, inserted through a tiny incision to the treatment site.
The thermal energy has the added advantage of tissue tightening via simultaneous photo-stimulation of dermal collagen.
Due to the coagulation properties of Nd:YAG lasers, there is less bruising or bleeding as compared to traditional liposuction for faster recovery.
As a complementary procedure to traditional liposuction, laser assisted lipolyis with LipoLite can treat smaller areas not possible with liposuction.
Product page: LipoLite…
Press release: Syneron’s LipoLite(TM) Minimally Invasive Laser-Assisted Lypolysis Receives FDA Clearance.